AstraZeneca Acquires Modella AI: Oncology Foundation Models
Analyze AstraZeneca's acquisition of Modella AI. Learn how multimodal foundation models integrate into oncology drug discovery and impact pharma AI M&A trends.
Back to Articles
Articles tagged with “foundation-models”
NVIDIA-Eli Lilly AI Lab: Drug Discovery Compute Strategy
An overview of the $1B NVIDIA-Eli Lilly AI lab, detailing its 5-year compute strategy, DGX SuperPOD infrastructure, and foundation models for drug discovery.
Open-Source AI Drug Discovery: Boltz-Pfizer Analysis
Analyze the Boltz-Pfizer AI drug discovery partnership. This report examines the application of open-source biomolecular foundation models in pharma R&D.
Fine-Tuning Foundation Models for Pharmaceutical R&D
Examine how fine-tuning foundation models and LLMs improves pharmaceutical R&D and drug discovery. Review Insilico's MMAI Gym methodology and AI benchmarks.
Latest AI Research (Dec 2025): GPT-5, Agents & Trends
An educational summary of late 2025 AI research papers. Learn about advances in foundation models like GPT-5, agentic AI, and new neuromorphic hardware.
AI in Radiology: 2025 Trends, FDA Approvals & Adoption
A 2025 overview of AI in radiology, covering FDA approvals, clinical adoption rates, and key technologies from CNNs to foundation models for medical imaging.
NVIDIA BioNeMo Explained: Generative AI in Drug Discovery
Updated 2026: Learn what NVIDIA BioNeMo is and how it accelerates drug discovery. This guide explains its components, latest models (RNAPro, ReaSyn v2), the $1B Lilly partnership, and deployment for generative AI in biopharma.
Top Imaging & Pathology AI Companies: 2025 Market Analysis
An in-depth 2025 analysis of the leading medical imaging and digital pathology AI vendors. Covers market size, deep learning trends, and top company profiles.
An Overview of Chinese Open-Source LLMs (Sept 2025)
An analysis of China's open-source LLM landscape in 2025. Covers key models like Qwen, Ernie, and GLM from major tech firms and leading AI startups.